Hot Blue Chip Stocks To Own For 2018


Much has been made of the stock markets record-setting performance since President Donald Trump won the race for the White House back in November.

Read: Yellen may have the clearest explanation for the stock markets record run

But Dow Joness data team offers more insight into how Trump stacks up compared with other presidents in their first 30 days in office, a milepost Trump hits on Feb. 19. The Dow Jones Industrial Average DJIA, +0.02% has returned 4.02% as of Fridays close, which would make the Dows performance in the Trump eras first month the sixth best in percentage terms behind Franklin D. Roosevelt in 1945, after his fourth victorious campaign for the presidency, when blue chips climbed by 4.1%.

Hot Blue Chip Stocks To Own For 2018: Mechel OAO(MTL)


Advisors’ Opinion:

  • [By Javier Hasse]

    Steel stocks are spiking on Monday afternoon, with AK Steel Holding Corporation (NYSE: AKS) up almost 7.5 percent, United States Steel Corporation (NYSE: X) up about 6.4 percent, Cliffs Natural Resources Inc (NYSE: CLF) up more than 1 percent and Mechel PAO (ADR) (NYSE: MTL) up 16.8 percent. The stocks are not being helped by a few analyst upgrades (although, surely not hurt by them), but seem to be mostly rallying on the back of Donald Trump’s election as president of the United States.

  • [By Shanthi Rexaline]

    Mechel PAO (ADR) (NYSE: MTL) is rallying strongly, rising to a three-year high on roughly 1.7 times its average volume.

    The stock has been on a tear in recent months. After dipping below the $2 level in late April and languishing in the sub-$2 range until August, the stock has nearly tripled in the run up to Monday’s session.

  • [By Lisa Levin]

    Basic materials shares climbed by 2.37 percent in trading on Wednesday. Meanwhile, top gainers in the sector included Handy & Harman Ltd (NYSE: HNH), and Mechel PAO (ADR) (NYSE: MTL).

  • [By Lisa Levin]

    Basic materials shares gained around 1.89 percent in trading on Tuesday. Meanwhile, top gainers in the sector included Olympic Steel, Inc. (NASDAQ: ZEUS), and Mechel PAO (ADR) (NYSE: MTL).

Hot Blue Chip Stocks To Own For 2018: Tesoro Corporation(TSO)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    U.S. oil refiner Tesoro (NYSE: TSO) said it would buy Western Refining (NYSE: WNR) for $4.1 billion to add refineries in Texas, New Mexico and Minnesota. The combined company will have refining capacity of over 1.1 million barrels per day. Tesoro has refineries in California, Washington, Alaska, Utah and North Dakota.

Hot Blue Chip Stocks To Own For 2018: Corning Incorporated(GLW)


Advisors’ Opinion:

  • [By Laurie Kulikowski]

    We believe 4K TV demand is ramping strongly, and management execution has been solid in our opinion. We also note the company’s focus on increased shareholder returns. Overall, we see the stock as undervalued on an ex-cash P/E basis despite growing EPS faster than peers. 

  • [By Laurie Kulikowski]

    The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. When compared to other companies in the Electronic Equipment, Instruments & Components industry and the overall market, CORNING INC’s return on equity is below that of both the industry average and the S&P 500.


     

  • [By Steve Symington]

    Corning Incorporated (NYSE:GLW) will release fourth-quarter 2016 results on Tuesday, Jan. 24, 2017. With shares up more than 44% over the past year, including a modest 4% climb since last quarter’s solid report in October, you can be sure the market will be listening closely to what the glass technologist says. What should investors watch for this time around?

Hot Blue Chip Stocks To Own For 2018: LKQ Corporation(LKQ)


Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

Hot Blue Chip Stocks To Own For 2018: Tiffany & Co.(TIF)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Finally on Friday, Tiffany (TIF) reports, and Cramer is betting on positive news now that the company has an activist involved. He was also bullish on Amgen’s (AMGN) analyst meeting, saying investors should use any market weakness earlier in the week to buy.

  • [By Peter Graham]

    Large cap luxury accessories stock Tiffany & Co (NYSE: TIF)reported Q1 earnings before the market opened this morning. Worldwide net sales rose 1% to $900 million due to growth in Asia-Pacific and an increase in the wholesale sale of diamonds whilecomparable store sales were 3% below the prior year. On a constant-exchange-rate basis that excludes the effect of translating foreign-currency-denominated sales into U.S. dollars, worldwide net sales increased 2% due to factors noted above along with sales growth in Europe while comparable store sales declined 2%. Higher fashion and designer jewelry sales contrasted with softness in other categories. On a region by region basis:

  • [By Ben Levisohn]

    Tiffany (TIF) rose to the top of the S&P 500 today after Richemont said it had seen strong jewelry sales, buoying luxury retailers.

    Agence France-Presse/Getty Images

    Tiffanygained 3.6% to $80.55 today, while the S&P 500 declined 0.2% to 2,270.44.

    In a report from Jan. 6, Macquarie’sLaurent Vasilescu and Dan Isaacson pondered the impact of commodity prices on Tiffany:

    Commodity Benefit Ending: In Section 1 on pages 2 through 9, we go through the math to show how the commodity tailwind is ending. We note that 2012 GMs were down 200bps YoY after the 2010/2011 commodity rally. Beyond precious metal, our London-based colleague Patrick Morton outlines in his November note that diamond prices will remain rather mute for the near term…we are calling for flattish to 30bps of gross margin expansion for FY17.


    Tiffany’s market capitalization rose to $10 billion today from $9.7 billion yesterday. It reported net income of $464 million on sales of $4.1 billion in fiscal 2016.

  • [By Ben Levisohn]

    Cowen’s Oliver Chen and team explain why they named Tiffany (TIF) one of their best ideas for 2017:

    Getty Images

    We are optimistic on Tiffany’s near- and long-term prospects. In the near-term, we have conviction on achievability of FY16 guidance and return to growth in 2017. Our view is that fundamentals will drive EPS upside–specifically, improved momentum in comp store sales through a combination of traffic and unit improvements. As we look to the longer term, our positive view is driven by: (1) modernization of product portfolio towards self-purchase in addition to Tiffany as a gifting destination; (2) category strength in areas such as bridal & engagement jewelry (29% of total revenue mix); (3) Tiffany’s opportunities to leverage its iconic long-term brand equity; (4) substantial barriers to entry with a highly evolved global supply chain, including in-house diamond operations and mining/manufacturing in Botswana; (5) management’s focus on vertical integration through systems/capital investments to advance global procurement, which is expected to gener ate longer-term cost savings; and (6) ample runway to grow e-commerce (online sales currently an est. ~6% of total revenue mix). Factors under Tiffanys control such as better inventory management and an omni-channel program and strategy are also strong positives.


    Shares of Tiffany have risen 0.6% to $84.87.

  • [By Lisa Levin]

    Tiffany & Co. (NYSE: TIF) reported better-than-expected results for its third quarter.

    Tiffany posted quarterly earnings of $95.1 million, or $0.76 per share, versus earnings of $91 million, or $0.70 per share.

Hot Blue Chip Stocks To Own For 2018: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

  • [By Lisa Levin] Gainers Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate. Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA. Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17. Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents. Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash. TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone. Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA. Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday. Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million. Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday. Sorl Auto
  • [By Brian Orelli]

    TG Therapeutics (NASDAQ:TGTX)rose 15% today, after an analyst at Jefferies initiated coverage with a buy and a $23 price target.

    So what

    Analyst action often has an effect on company’s stock price, especially in the short term, but today’s move may be exacerbated by an upcoming data release at the American Academy of Neurology meeting scheduled for Friday. Investors may have been jumping in today ahead of the binary event, hoping that Friday’s data will be positive enough to send the share price even higher.

Leave a Reply

Your email address will not be published. Required fields are marked *